
Brian A. Whiteman
Examiner (ID: 16463, Phone: (571)272-0764 , Office: P/1674 )
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1635, 1636, 1633, 1674 |
| Total Applications | 1739 |
| Issued Applications | 920 |
| Pending Applications | 243 |
| Abandoned Applications | 617 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18297965
[patent_doc_number] => 20230107651
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => METHODS OF TREATING SPINAL MUSCULAR ATROPHY
[patent_app_type] => utility
[patent_app_number] => 17/819742
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24993
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17819742
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/819742 | METHODS OF TREATING SPINAL MUSCULAR ATROPHY | Aug 14, 2022 | Abandoned |
Array
(
[id] => 18058340
[patent_doc_number] => 20220389426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => miRNA AS BIOMARKER FOR PARKINSON'S DISEASE AND DIAGNOSTIC KIT USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/888084
[patent_app_country] => US
[patent_app_date] => 2022-08-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7563
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17888084
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/888084 | miRNA AS BIOMARKER FOR PARKINSON'S DISEASE AND DIAGNOSTIC KIT USING SAME | Aug 14, 2022 | Abandoned |
Array
(
[id] => 18389840
[patent_doc_number] => 20230158058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-25
[patent_title] => METHODS AND COMPOSITIONS FOR TREATING A BLEEDING EVENT IN A SUBJECT HAVING HEMOPHILIA
[patent_app_type] => utility
[patent_app_number] => 17/878884
[patent_app_country] => US
[patent_app_date] => 2022-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54778
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17878884
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/878884 | METHODS AND COMPOSITIONS FOR TREATING A BLEEDING EVENT IN A SUBJECT HAVING HEMOPHILIA | Jul 31, 2022 | Pending |
Array
(
[id] => 18420525
[patent_doc_number] => 20230174987
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => Modulation of Dystrophia Myotonica-Protein Kinase (DMPK) Expression
[patent_app_type] => utility
[patent_app_number] => 17/814120
[patent_app_country] => US
[patent_app_date] => 2022-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39524
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17814120
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/814120 | Modulation of dystrophia myotonica-protein kinase (DMPK) expression | Jul 20, 2022 | Issued |
Array
(
[id] => 19930332
[patent_doc_number] => 12303525
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-20
[patent_title] => Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection
[patent_app_type] => utility
[patent_app_number] => 17/813576
[patent_app_country] => US
[patent_app_date] => 2022-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 28
[patent_no_of_words] => 43142
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813576
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/813576 | Nucleic acid molecule for reduction of PAPD5 and PAPD7 mRNA for treating hepatitis B infection | Jul 18, 2022 | Issued |
Array
(
[id] => 18196503
[patent_doc_number] => 20230050022
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-16
[patent_title] => COMPOSITIONS AND METHODS RELATED TO TRANSFERRIN RECEPTOR-BINDING APTAMERS
[patent_app_type] => utility
[patent_app_number] => 17/813021
[patent_app_country] => US
[patent_app_date] => 2022-07-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17813021
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/813021 | COMPOSITIONS AND METHODS RELATED TO TRANSFERRIN RECEPTOR-BINDING APTAMERS | Jul 14, 2022 | Pending |
Array
(
[id] => 18466962
[patent_doc_number] => 20230201242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => RIG-I AGONISTS AND METHODS USING SAME
[patent_app_type] => utility
[patent_app_number] => 17/864199
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29192
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17864199
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/864199 | RIG-I AGONISTS AND METHODS USING SAME | Jul 12, 2022 | Abandoned |
Array
(
[id] => 18895550
[patent_doc_number] => 20240011035
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => METHODS RELATING TO CIRCULATING TUMOR CELL CLUSTERS AND THE TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 17/863984
[patent_app_country] => US
[patent_app_date] => 2022-07-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17863984
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/863984 | METHODS RELATING TO CIRCULATING TUMOR CELL CLUSTERS AND THE TREATMENT OF CANCER | Jul 12, 2022 | Abandoned |
Array
(
[id] => 18530264
[patent_doc_number] => 20230235334
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => PHOSPHORYLATION-BASED MIRNA SENSOR
[patent_app_type] => utility
[patent_app_number] => 17/811593
[patent_app_country] => US
[patent_app_date] => 2022-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19477
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17811593
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/811593 | Phosphorylation-based miRNA sensor | Jul 10, 2022 | Issued |
Array
(
[id] => 18345814
[patent_doc_number] => 20230133924
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-05-04
[patent_title] => OPTIMIZED EXPRESSION CASSETTES FOR GENE THERAPY
[patent_app_type] => utility
[patent_app_number] => 17/811549
[patent_app_country] => US
[patent_app_date] => 2022-07-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 51684
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -100
[patent_words_short_claim] => 116
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17811549
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/811549 | OPTIMIZED EXPRESSION CASSETTES FOR GENE THERAPY | Jul 7, 2022 | Pending |
Array
(
[id] => 18077783
[patent_doc_number] => 20220403395
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => COMPOSITION FOR INHIBITING GROWTH OF CANCER STEM CELLS, CONTAINING WDR34 INHIBITOR, AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/851500
[patent_app_country] => US
[patent_app_date] => 2022-06-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8388
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17851500
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/851500 | COMPOSITION FOR INHIBITING GROWTH OF CANCER STEM CELLS, CONTAINING WDR34 INHIBITOR, AND USE THEREOF | Jun 27, 2022 | Pending |
Array
(
[id] => 18226726
[patent_doc_number] => 20230065720
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => High Throughput Cell-Based Screening for Aptamers
[patent_app_type] => utility
[patent_app_number] => 17/809043
[patent_app_country] => US
[patent_app_date] => 2022-06-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14490
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17809043
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/809043 | High Throughput Cell-Based Screening for Aptamers | Jun 26, 2022 | Abandoned |
Array
(
[id] => 19915227
[patent_doc_number] => 12290573
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-05-06
[patent_title] => Modified RNAi agents
[patent_app_type] => utility
[patent_app_number] => 17/848850
[patent_app_country] => US
[patent_app_date] => 2022-06-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26130
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 219
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17848850
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/848850 | Modified RNAi agents | Jun 23, 2022 | Issued |
Array
(
[id] => 17990437
[patent_doc_number] => 20220356474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => NUCLEIC ACID, COMPOSITION AND CONJUGATE COMPRISING THE SAME, PREPARATION METHOD AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/847770
[patent_app_country] => US
[patent_app_date] => 2022-06-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46551
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17847770
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/847770 | Nucleic acid, composition and conjugate comprising the same, preparation method and use thereof | Jun 22, 2022 | Issued |
Array
(
[id] => 18058337
[patent_doc_number] => 20220389423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => Compositions and Methods for Simultaneously Modulating Expression of Genes
[patent_app_type] => utility
[patent_app_number] => 17/846288
[patent_app_country] => US
[patent_app_date] => 2022-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88637
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17846288
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/846288 | Compositions and Methods for Simultaneously Modulating Expression of Genes | Jun 21, 2022 | Pending |
Array
(
[id] => 18226046
[patent_doc_number] => 20230065040
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-02
[patent_title] => SUBCUTANEOUS DELIVERY OF MESSENGER RNA
[patent_app_type] => utility
[patent_app_number] => 17/841194
[patent_app_country] => US
[patent_app_date] => 2022-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17355
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17841194
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/841194 | SUBCUTANEOUS DELIVERY OF MESSENGER RNA | Jun 14, 2022 | Pending |
Array
(
[id] => 19701719
[patent_doc_number] => 12195734
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-01-14
[patent_title] => Deaminase-based RNA sensors
[patent_app_type] => utility
[patent_app_number] => 17/806879
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 111
[patent_figures_cnt] => 168
[patent_no_of_words] => 22384
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 172
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17806879
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/806879 | Deaminase-based RNA sensors | Jun 13, 2022 | Issued |
| 17/769384 | METHOD FOR PREPARING CELL-FREE PROTEIN EXPRESSION GEL USING PLASMID | Jun 12, 2022 | Abandoned |
Array
(
[id] => 18286356
[patent_doc_number] => 20230101828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-30
[patent_title] => KISSPEPTIN 1 (KISS1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/837479
[patent_app_country] => US
[patent_app_date] => 2022-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 58063
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17837479
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/837479 | KISSPEPTIN 1 (KISS1) IRNA COMPOSITIONS AND METHODS OF USE THEREOF | Jun 9, 2022 | Abandoned |
Array
(
[id] => 18123928
[patent_doc_number] => 20230009539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-12
[patent_title] => SBE APTAMERS FOR TREATING IL-17a RELATED DISEASES AND CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/833323
[patent_app_country] => US
[patent_app_date] => 2022-06-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17026
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17833323
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/833323 | SBE APTAMERS FOR TREATING IL-17a RELATED DISEASES AND CONDITIONS | Jun 5, 2022 | Pending |